Transcatheter device closure of atrial septal defects: a safety review

John Moore; Sanjeet Hegde; Howaida El-Said; Robert Beekman 3rd; Lee Benson; Lisa Bergersen; Ralf Holzer; Kathy Jenkins; Richard Ringel; Jonathan Rome; Robert Vincent; Gerard Martin; ACC IMPACT Steering Committee

doi:10.1016/j.jcin.2013.02.005

Transcatheter device closure of atrial septal defects: a safety review

JACC Cardiovasc Interv. 2013 May;6(5):433-42. doi: 10.1016/j.jcin.2013.02.005.

Authors

John Moore¹, Sanjeet Hegde, Howaida El-Said, Robert Beekman 3rd, Lee Benson, Lisa Bergersen, Ralf Holzer, Kathy Jenkins, Richard Ringel, Jonathan Rome, Robert Vincent, Gerard Martin; ACC IMPACT Steering Committee

Affiliation

¹ Department of Pediatrics, Division of Cardiology, Rady Children's Hospital, University of California, San Diego, San Diego, California 92123, USA. [email protected]

PMID: 23702008
DOI: 10.1016/j.jcin.2013.02.005

Abstract

This review discusses the current safety issues related to U.S. Food and Drug Administration approved atrial septal defect devices and proposes a potential avenue to gather additional safety data including factors, which may be involved in device erosion.

Publication types

Review

MeSH terms

Arrhythmias, Cardiac / etiology
Cardiac Catheterization / adverse effects*
Cardiac Catheterization / instrumentation*
Cardiac Catheterization / standards
Device Approval
Foreign-Body Migration / etiology
Heart Septal Defects, Atrial / diagnosis
Heart Septal Defects, Atrial / therapy*
Humans
Hypersensitivity / etiology
Practice Guidelines as Topic
Product Surveillance, Postmarketing
Prosthesis Design
Prosthesis Failure
Prosthesis-Related Infections / etiology
Registries
Risk Assessment
Risk Factors
Septal Occluder Device* / standards
Thromboembolism / etiology
Treatment Outcome
United States
United States Food and Drug Administration

Supplementary concepts

Atrial Septal Defect, Secundum Type